• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Who decides when to start preventive treatment? A questionnaire survey to compare the views of different population subgroups.

作者信息

Lewis D K, Barton S

机构信息

Vauxhall Primary Health Care, Liverpool, UK.

出版信息

J Epidemiol Community Health. 2003 Apr;57(4):241-2. doi: 10.1136/jech.57.4.241.

DOI:10.1136/jech.57.4.241
PMID:12646536
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1732436/
Abstract
摘要

相似文献

1
Who decides when to start preventive treatment? A questionnaire survey to compare the views of different population subgroups.谁来决定何时开始预防性治疗？一项比较不同人群亚组观点的问卷调查。
J Epidemiol Community Health. 2003 Apr;57(4):241-2. doi: 10.1136/jech.57.4.241.
2
[KLAS [Kanazawa Lipid Assessment Survey]].
Nihon Rinsho. 2001 Mar;59 Suppl 3:469-76.
3
[Helsinki Heart Study].[赫尔辛基心脏研究]
Nihon Rinsho. 2001 Mar;59 Suppl 3:404-9.
4
Currently available lipid-lowering agents.
Hosp Pract (Off Ed). 1988 Jun;23 Suppl 1:14-21. doi: 10.1080/21548331.1988.11703634.
5
[Fibrates: mechanism of action, effect on levels of lipids and risk of coronary events. II. Fenofibrate].[纤维酸类药物：作用机制、对血脂水平的影响及冠状动脉事件风险。II. 非诺贝特]
Kardiologiia. 2004;44(3):87-93.
6
Practical drug therapy for common hyperlipidaemias.常见高脂血症的实用药物治疗
Baillieres Clin Endocrinol Metab. 1990 Dec;4(4):719-42. doi: 10.1016/s0950-351x(05)80077-1.
7
[Therapeutic management of the dyslipidemic patient].[血脂异常患者的治疗管理]
Ann Endocrinol (Paris). 2001 Feb;62(1 Pt 1):70-5.
8
Primary prevention of coronary heart disease: where do we go from here?冠心病的一级预防：我们从这里何去何从？
Arch Intern Med. 2001 Apr 9;161(7):922-4. doi: 10.1001/archinte.161.7.922.
9
[Overviews of fibrate].[贝特类药物概述]
Nihon Rinsho. 2001 Mar;59 Suppl 3:609-17.
10
Lipid disorders in NIDDM: implications for treatment.
J Intern Med. 1998 Nov;244(5):361-70. doi: 10.1046/j.1365-2796.1998.00397.x.

引用本文的文献

1
Surveys of parents and clinicians concerning the minimally important difference of probiotic therapy for prevention of paediatric antibiotic-associated diarrhoea.家长和临床医生对益生菌疗法预防儿童抗生素相关性腹泻的最小重要差异的调查。
BMJ Open. 2019 Apr 2;9(4):e024651. doi: 10.1136/bmjopen-2018-024651.
2
Patient and general practitioner attitudes to taking medication to prevent cardiovascular disease after receiving detailed information on risks and benefits of treatment: a qualitative study.患者和全科医生在接受关于治疗风险和益处的详细信息后对服用预防心血管疾病药物的态度：一项定性研究。
BMC Fam Pract. 2011 Jun 26;12:59. doi: 10.1186/1471-2296-12-59.
3
Predictors of patients' preferences for treatments to prevent heart disease.患者对预防心脏病治疗方法偏好的预测因素。
Heart. 2006 Nov;92(11):1651-5. doi: 10.1136/hrt.2005.072405. Epub 2006 May 18.
4
Improving management of hypertension in general practice: a randomised controlled trial of feedback derived from electronic patient data.改善基层医疗中高血压的管理：一项源自电子患者数据反馈的随机对照试验
Br J Gen Pract. 2005 Feb;55(511):94-101.
5
Clinicians' preferences for treatments to prevent coronary heart disease: a postal survey.临床医生对预防冠心病治疗方法的偏好：一项邮寄问卷调查。
Heart. 2005 Mar;91(3):377-8. doi: 10.1136/hrt.2004.035196.
6
Factors involved in deciding to start preventive treatment: qualitative study of clinicians' and lay people's attitudes.决定开始预防性治疗的相关因素：临床医生和普通民众态度的定性研究
BMJ. 2003 Oct 11;327(7419):841. doi: 10.1136/bmj.327.7419.841.